Chronic anemia as a manifestation of MELAS syndrome

Revista de Investigacion Clinica

Volumn 63, Issue 1, 2011, Pages 100-103

  Finsterer, Josef ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN A; HEMOGLOBIN A2; HEMOGLOBIN F; IRON; LACTIC ACID; LAMOTRIGINE; LORAZEPAM; N ACETYLASPARTIC ACID; TRANSFERRIN;

ADULT; ANEMIA; CASE REPORT; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPHY; EVOKED VISUAL RESPONSE; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; LETTER; MELAS SYNDROME; MICROCYTIC ANEMIA; MILD COGNITIVE IMPAIRMENT; MUSCLE BIOPSY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PTOSIS; REFLEX DISORDER; SHORT STATURE; SUBSTITUTION THERAPY; THROMBOCYTOSIS; TRANSFERRIN BLOOD LEVEL; VISUAL FIELD DEFECT;

ADULT; ANEMIA; CHRONIC DISEASE; FEMALE; HUMANS; MELAS SYNDROME;

EID: 79955823060     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. Zeviani M. Mitochondrial disorders. Suppl Clin Neurophysiol 2004;57:304-12.
2. Zaffanello M, Zamboni G. Therapeutic approach in a case of Pearson's syndrome. Minerva Pediatr 2005;57:143-6. (Pubitemid 44251889)
3. Inbal A, Avissar N, Shaklai M, Kuritzky A, Schejter A, Ben-David E, Shanske S, Garty BZ. Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. Am J Med Genet 1995;55:372-8.
4. Muraki K, Nishimura S, Goto Y, Nonaka I, Sakura N, Ueda K. The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis 1997;20:697-703. (Pubitemid 27417644)
5. Reichenbach J, Schubert R, Horvath R, Petersen J, Futterer N, Malle E, Stumpf A, et al. Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency. Pediatr Res 2006;60:321-6. (Pubitemid 44267746)
6. Espinosa G, Bucciarelli S, Cervera R, Lozano M, Reverter JC, de la Red G, Gil V, et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 2004;63:730-6. (Pubitemid 38658405)
7. Finsterer J. MELAS syndrome as a differential diagnosis of ischemic stroke. Fortschr Neurol Psychiatr 2009;77:25-31.
8. Finsterer J. Hematological manifestations of primary mitochondrial disorders. Acta Haematol 2007;118:88-98. (Pubitemid 47413792)
9. Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol 2005;11:14-23. (Pubitemid 40444028)
10. Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004;74:1303-8. (Pubitemid 38669331)
11. Dan K. Thrombocytosis in iron deficiency anemia. Intern Med 2005;44:1025-6. (Pubitemid 41715747)
12. Rubio-Gozalbo ME, Sengers RC, Trijbels JM, Doesburg WH, Janssen AJ, Verbeek AL, Smeitink JA. A prognostic index as diagnostic strategy in children suspected of mitochondriocytopathy. Neuropediatrics 2000;31:114-21. (Pubitemid 30495434)